| abstract |
An object of the present invention is to provide a particulate anticancer agent, an anticancer composition comprising the particle, and a method of using the particle. Dispersible particles comprising a crystalline anticancer agent having a surface modifier adsorbed on the surface in an amount substantially sufficient to maintain an average effective particle size of less than about 1000 nm. The anticancer composition comprising the particles exhibits reduced toxicity and / or increased efficacy and can be administered by injection. [Selection figure] None |